Compare NTB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | TMDX |
|---|---|---|
| Founded | 1858 | 1998 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2016 | 2019 |
| Metric | NTB | TMDX |
|---|---|---|
| Price | $55.51 | $67.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $66.00 | ★ $98.73 |
| AVG Volume (30 Days) | 128.4K | ★ 807.7K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $5.42 | $22.50 |
| Revenue Next Year | $86.83 | $17.97 |
| P/E Ratio | ★ $9.64 | $109.77 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $44.36 | $60.11 |
| 52 Week High | $64.17 | $156.00 |
| Indicator | NTB | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.16 | 32.70 |
| Support Level | $54.30 | $66.77 |
| Resistance Level | $56.59 | $71.14 |
| Average True Range (ATR) | 1.07 | 3.64 |
| MACD | -0.32 | -0.33 |
| Stochastic Oscillator | 1.19 | 19.84 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.